会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Antibodies that bind human prostate specific G-protein receptor HPRAJ70
    • 结合人前列腺特异性G蛋白受体HPRAJ70的抗体
    • US06824993B2
    • 2004-11-30
    • US09968033
    • 2001-10-02
    • Daniel R. SoppetYi LiCraig A. RosenSteven M. Ruben
    • Daniel R. SoppetYi LiCraig A. RosenSteven M. Ruben
    • C07K1618
    • C07K16/28A61K38/00A61K39/00A61K2039/505C07K14/705C07K2317/622
    • The present invention relates to PSGR, a novel prostate specific gene with homology to a G-protein coupled receptor overexpressed in prostate cancer. More specifically, the invention relates to PSGR polynucleotides and the polypeptides encoded by these polynucleotides, and the use of PSGR polynucleotides and polypeptides for detecting disorders of the reproductive system, including disorders of the prostate, particularly the presence of cancer. This invention relates to PSGR polynucleotides and polypeptides as well as vectors, host cells, antibodies directed to PSGR polynucleotides and polypeptides and recombinant and synthetic methods for producing the same. Also provided are methods for diagnosing, treating, preventing, and/or prognosing disorders related to the prostate, including cancer. The invention further relates to screening methods for identifying agonists and antagonists of PSGR polynucleotides and polypeptides of the invention and methods and/or compositions for inhibiting or enhancing the production and/or function of the PSGR polypeptides of the present invention.
    • 本发明涉及PSGR,一种与在前列腺癌中过表达的G蛋白偶联受体具有同源性的新型前列腺特异性基因。 更具体地,本发明涉及PSGR多核苷酸和由这些多核苷酸编码的多肽,以及使用PSGR多核苷酸和多肽来检测生殖系统疾病,包括前列腺疾病,特别是癌症的存在。 本发明涉及PSGR多核苷酸和多肽以及载体,宿主细胞,针对PSGR多核苷酸和多肽的抗体以及用于制备它的重组和合成方法。 还提供了用于诊断,治疗,预防和/或预后与前列腺相关的疾病(包括癌症)的方法。 本发明还涉及用于鉴定本发明的PSGR多核苷酸和多肽的激动剂和拮抗剂的筛选方法以及用于抑制或增强本发明的PSGR多肽的产生和/或功能的方法和/或组合物。
    • 9. 发明授权
    • Method of producing an antibody to G-protein parathyroid hormone receptor HLTDG74
    • 产生G蛋白甲状旁腺激素受体HLTDG74抗体的方法
    • US07393650B2
    • 2008-07-01
    • US10921218
    • 2004-08-19
    • Daniel R. SoppetYi LiCraig A. RosenSteven M. Ruben
    • Daniel R. SoppetYi LiCraig A. RosenSteven M. Ruben
    • G01N33/53C07K16/28C07K14/72
    • C07K14/723A61K48/00C12N2799/026
    • Human G-protein parathyroid hormone (PTH) receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the PTH receptor receptor polypeptides. Also disclosed are diagnostic methods for detecting a mutation in the PTH receptor receptor nucleic acid sequences and detecting a level of the soluble form of the receptors in a sample derived from a host. Disclosed embodiments of the invention also include antibodies that bind Human G-Protein parathyroid hormone (PTH) receptor polypeptides and methods for making and using such antibodies.
    • 公开了人类G蛋白甲状旁腺激素(PTH)受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及在治疗上使用激动剂和拮抗剂治疗与PTH受体受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测PTH受体受体核酸序列中的突变并检测衍生自宿主的样品中受体的可溶形式水平的诊断方法。 本发明的公开的实施方案还包括结合人类G蛋白甲状旁腺激素(PTH)受体多肽的抗体以及制备和使用这些抗体的方法。